HEADER CELL CYCLE, APOPTOSIS 14-MAR-11 2LAH TITLE SOLUTION NMR STRUCTURE OF MITOTIC CHECKPOINT SERINE/THREONINE-PROTEIN TITLE 2 KINASE BUB1 N-TERMINAL DOMAIN FROM HOMO SAPIENS, NORTHEAST STRUCTURAL TITLE 3 GENOMICS CONSORTIUM TARGET HR5460A (METHODS DEVELOPMENT) COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOTIC CHECKPOINT SERINE/THREONINE-PROTEIN KINASE BUB1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN; COMPND 5 SYNONYM: HBUB1, BUB1A; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BUB1, BUB1L; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET 14-15C KEYWDS STRUCTURAL GENOMICS, PROTEIN NMR, NORTHEAST STRUCTURAL GENOMICS KEYWDS 2 CONSORTIUM (NESG), TARGET HR5460A, PSI-BIOLOGY, PROTEIN STRUCTURE KEYWDS 3 INITIATIVE, CELL CYCLE, APOPTOSIS, METHODS DEVELOPMENT EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR G.LIU,R.XIAO,H.LEE,K.HAMILTON,T.B.ACTON,C.CICCOSANTI,J.K.EVERETT, AUTHOR 2 R.T.SHASTRY,Y.J.HUANG,G.T.MONTELIONE,N.NORTHEAST STRUCTURAL GENOMICS AUTHOR 3 CONSORTIUM,NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) REVDAT 2 14-JUN-23 2LAH 1 REMARK SEQADV REVDAT 1 11-MAY-11 2LAH 0 JRNL AUTH G.LIU,R.SHASTRY,C.CICCOSANTI,K.HAMILTON,T.B.ACTON,R.XIAO, JRNL AUTH 2 J.K.EVERETT,G.T.MONTELIONE JRNL TITL NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR5460A JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS, CYANA, CNS REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNS), BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-KUNSTLEVE,JIANG, REMARK 3 KUSZEWSKI,NILGES, PANNU,READ,RICE,SIMONSON,WARREN (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LAH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-MAR-11. REMARK 100 THE DEPOSITION ID IS D_1000102159. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.164 MM [U-100% 13C; U-100% REMARK 210 15N] HR5460A, 95% H2O/5% D2O; REMARK 210 1.033 MM [U-10% 13C; U-100% 15N] REMARK 210 HR5460A, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D HNCO; 3D CBCA(CO)NH; 3D REMARK 210 HNCACB; 3D 1H-13C AROM NOESY; 3D REMARK 210 SIMUTANEOUS 13C-AROMATIC,13C- REMARK 210 ALIPHATIC,15N EDITED 1H-1H NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; INOVA REMARK 210 SPECTROMETER MANUFACTURER : BRUKER; VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA 3.0, AUTOSTRUCTURE 2.1, REMARK 210 AUTOASSIGN 2.1, NMRPIPE, XEASY, REMARK 210 TOPSPIN, VNMRJ, SPARKY, TALOS+ REMARK 210 METHOD USED : DISTANCE GEOMETRY, TORSION ANGLE REMARK 210 DYNAMICS, SIMULATED ANNEALING, REMARK 210 MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 HIS A 4 -1.68 68.44 REMARK 500 1 HIS A 6 105.71 -56.76 REMARK 500 1 HIS A 8 100.74 -58.45 REMARK 500 1 LYS A 29 -71.88 -66.27 REMARK 500 1 ASP A 32 101.72 66.77 REMARK 500 2 HIS A 3 40.94 -144.42 REMARK 500 2 HIS A 7 89.92 -67.54 REMARK 500 2 TYR A 28 97.54 -66.12 REMARK 500 2 LYS A 29 77.06 -114.71 REMARK 500 2 GLU A 124 50.19 -93.91 REMARK 500 3 HIS A 3 87.11 -66.14 REMARK 500 3 HIS A 10 -71.68 -95.38 REMARK 500 3 LYS A 69 93.36 -68.85 REMARK 500 4 HIS A 5 -72.66 58.47 REMARK 500 4 SER A 9 87.19 -67.99 REMARK 500 4 LYS A 29 -85.68 62.07 REMARK 500 4 ASP A 32 80.13 58.50 REMARK 500 5 HIS A 4 99.83 -68.82 REMARK 500 5 MET A 11 89.97 -57.99 REMARK 500 5 ASP A 32 71.23 50.55 REMARK 500 6 HIS A 3 95.85 -67.80 REMARK 500 6 ASP A 32 142.57 -176.77 REMARK 500 7 HIS A 8 92.63 -57.14 REMARK 500 7 MET A 11 99.79 -163.53 REMARK 500 8 SER A 9 109.93 -59.82 REMARK 500 8 ASP A 12 -173.18 -67.55 REMARK 500 8 LYS A 69 88.71 -66.27 REMARK 500 8 ASP A 91 43.11 -99.76 REMARK 500 8 GLU A 124 46.84 -87.31 REMARK 500 9 LYS A 69 90.61 -69.00 REMARK 500 10 HIS A 6 96.31 -69.67 REMARK 500 10 SER A 9 94.35 -55.39 REMARK 500 10 MET A 11 54.91 -148.13 REMARK 500 10 ASP A 32 50.16 -147.54 REMARK 500 10 ALA A 140 100.91 -59.55 REMARK 500 11 HIS A 3 84.28 54.74 REMARK 500 11 HIS A 4 -156.89 -134.68 REMARK 500 11 ASP A 32 81.73 54.55 REMARK 500 11 GLN A 139 30.92 70.37 REMARK 500 12 HIS A 5 83.54 -68.08 REMARK 500 12 ASP A 32 78.38 50.48 REMARK 500 12 ASP A 91 46.77 -85.60 REMARK 500 12 GLU A 124 48.32 -84.23 REMARK 500 13 HIS A 5 -8.61 -151.74 REMARK 500 13 SER A 9 -0.84 65.53 REMARK 500 13 TYR A 28 106.07 -42.07 REMARK 500 14 HIS A 7 90.57 -61.29 REMARK 500 14 HIS A 10 -160.90 -79.94 REMARK 500 14 MET A 11 85.69 -65.31 REMARK 500 14 SER A 27 -30.31 -134.72 REMARK 500 REMARK 500 THIS ENTRY HAS 78 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 17524 RELATED DB: BMRB REMARK 900 RELATED ID: HR5460A RELATED DB: TARGETDB DBREF 2LAH A 11 160 UNP O43683 BUB1_HUMAN 1 150 SEQADV 2LAH MET A 1 UNP O43683 EXPRESSION TAG SEQADV 2LAH GLY A 2 UNP O43683 EXPRESSION TAG SEQADV 2LAH HIS A 3 UNP O43683 EXPRESSION TAG SEQADV 2LAH HIS A 4 UNP O43683 EXPRESSION TAG SEQADV 2LAH HIS A 5 UNP O43683 EXPRESSION TAG SEQADV 2LAH HIS A 6 UNP O43683 EXPRESSION TAG SEQADV 2LAH HIS A 7 UNP O43683 EXPRESSION TAG SEQADV 2LAH HIS A 8 UNP O43683 EXPRESSION TAG SEQADV 2LAH SER A 9 UNP O43683 EXPRESSION TAG SEQADV 2LAH HIS A 10 UNP O43683 EXPRESSION TAG SEQRES 1 A 160 MET GLY HIS HIS HIS HIS HIS HIS SER HIS MET ASP THR SEQRES 2 A 160 PRO GLU ASN VAL LEU GLN MET LEU GLU ALA HIS MET GLN SEQRES 3 A 160 SER TYR LYS GLY ASN ASP PRO LEU GLY GLU TRP GLU ARG SEQRES 4 A 160 TYR ILE GLN TRP VAL GLU GLU ASN PHE PRO GLU ASN LYS SEQRES 5 A 160 GLU TYR LEU ILE THR LEU LEU GLU HIS LEU MET LYS GLU SEQRES 6 A 160 PHE LEU ASP LYS LYS LYS TYR HIS ASN ASP PRO ARG PHE SEQRES 7 A 160 ILE SER TYR CYS LEU LYS PHE ALA GLU TYR ASN SER ASP SEQRES 8 A 160 LEU HIS GLN PHE PHE GLU PHE LEU TYR ASN HIS GLY ILE SEQRES 9 A 160 GLY THR LEU SER SER PRO LEU TYR ILE ALA TRP ALA GLY SEQRES 10 A 160 HIS LEU GLU ALA GLN GLY GLU LEU GLN HIS ALA SER ALA SEQRES 11 A 160 VAL LEU GLN ARG GLY ILE GLN ASN GLN ALA GLU PRO ARG SEQRES 12 A 160 GLU PHE LEU GLN GLN GLN TYR ARG LEU PHE GLN THR ARG SEQRES 13 A 160 LEU THR GLU THR HELIX 1 1 THR A 13 SER A 27 1 15 HELIX 2 2 PRO A 33 PHE A 48 1 16 HELIX 3 3 ASN A 51 PHE A 66 1 16 HELIX 4 4 LYS A 69 HIS A 73 5 5 HELIX 5 5 ASP A 75 GLU A 87 1 13 HELIX 6 6 ASP A 91 HIS A 102 1 12 HELIX 7 7 SER A 108 GLY A 123 1 16 HELIX 8 8 GLU A 124 GLN A 139 1 16 HELIX 9 9 PRO A 142 THR A 158 1 17 CISPEP 1 GLU A 141 PRO A 142 1 -5.68 CISPEP 2 GLU A 141 PRO A 142 2 -7.46 CISPEP 3 GLU A 141 PRO A 142 3 -7.11 CISPEP 4 GLU A 141 PRO A 142 4 -10.10 CISPEP 5 GLU A 141 PRO A 142 5 -1.38 CISPEP 6 GLU A 141 PRO A 142 6 -7.94 CISPEP 7 GLU A 141 PRO A 142 7 -7.78 CISPEP 8 GLU A 141 PRO A 142 8 -7.04 CISPEP 9 GLU A 141 PRO A 142 9 -7.56 CISPEP 10 GLU A 141 PRO A 142 10 -6.66 CISPEP 11 GLU A 141 PRO A 142 11 -5.60 CISPEP 12 GLU A 141 PRO A 142 12 -4.66 CISPEP 13 GLU A 141 PRO A 142 13 -4.61 CISPEP 14 GLU A 141 PRO A 142 14 -4.00 CISPEP 15 GLU A 141 PRO A 142 15 -3.65 CISPEP 16 GLU A 141 PRO A 142 16 -1.43 CISPEP 17 GLU A 141 PRO A 142 17 -9.57 CISPEP 18 GLU A 141 PRO A 142 18 -3.19 CISPEP 19 GLU A 141 PRO A 142 19 -8.78 CISPEP 20 GLU A 141 PRO A 142 20 -6.94 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1